DrugPatentWatch Database Preview

Alpharma Company Profile

ALPHARMA has sixty-three approved drugs.

There are nine US patents protecting ALPHARMA drugs.

There are forty-nine patent family members on ALPHARMA drugs in twenty-two countries and six supplementary protection certificates in two countries.

International Patents:	49
US Patents:	9
Tradenames:	45
Ingredients:	42
NDAs:	63
Patent Litigation for Alpharma:	See patent lawsuits for Alpharma

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	ERYTHROMYCIN	erythromycin	SOLUTION;TOPICAL	062326-001	Apr 19, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Us Pharms	THIOTHIXENE HYDROCHLORIDE	thiothixene hydrochloride	CONCENTRATE;ORAL	070969-001	Oct 16, 1987		DISCN	No	No		➤ Sign Up				➤ Sign Up
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-006	Aug 13, 2009		RX	Yes	No	8,685,443	➤ Sign Up				➤ Sign Up
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009		RX	Yes	No	8,846,104	➤ Sign Up	Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-006	Aug 13, 2009	5,378,474	➤ Sign Up
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009	5,378,474	➤ Sign Up
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-006	Aug 13, 2009	5,202,128	➤ Sign Up
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-001	Aug 13, 2009	5,202,128	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	30 mg/1.2 mg, 50 mg/2 mg and 80 mg/3.2 mg	➤ Subscribe	2010-05-28
➤ Subscribe	Extended-release Capsules	100 mg/4 mg	➤ Subscribe	2010-05-03
➤ Subscribe	Extended-release Capsules	60 mg/2.4 mg	➤ Subscribe	2010-05-25

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB10/012	United Kingdom	➤ Sign Up	PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112
C/GB12/058	United Kingdom	➤ Sign Up	PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
C/GB98/013	United Kingdom	➤ Sign Up	PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
C0012	France	➤ Sign Up	PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.